Literature DB >> 23528286

Divergent systemic and local inflammatory response to hind limb demand ischemia in wild-type and ApoE-/- mice.

Robert S Crawford1, Hassan Albadawi, Alessandro Robaldo, Michael A Peck, Christopher J Abularrage, Hyung-Jin Yoo, Glenn M Lamuraglia, Michael T Watkins.   

Abstract

BACKGROUND: We designed studies to determine whether the ApoE-/- phenotype modulates the local skeletal muscle and systemic inflammatory (plasma) responses to lower extremity demand ischemia. The ApoE-/- phenotype is an experimental model for atherosclerosis in humans.
METHODS: Aged female ApoE-/- and C57BL6 mice underwent femoral artery ligation, then were divided into sedentary and demand ischemia (exercise) groups on day 14. We assessed baseline and postexercise limb perfusion and hind limb function. On day 14, animals in the demand ischemia group underwent daily treadmill exercise through day 28. Sedentary mice were not exercised. On day 28, we harvested plasma and skeletal muscle from ischemic limbs from sedentary and exercised mice. We assayed muscle for angiogenic and proinflammatory proteins, markers of skeletal muscle regeneration, and evidence of skeletal muscle fiber maturation.
RESULTS: Hind limb ischemia was similar in ApoE-/- and C57 mice before the onset of exercise. Under sedentary conditions, plasma vascular endothelial cell growth factor and interleukin-6, but not keratinocyte chemoattractant factor (KC) or macrophage inflammatory protein-2 (MIP-2), were higher in ApoE (P < 0.0001). After exercise, plasma levels of vascular endothelial cell growth factor, KC, and MIP-2, but not IL-6, were lower in ApoE (P < 0.004). The cytokines KC and MIP-2 in muscle were greater in exercised ApoE-/- mice compared with C57BL6 mice (P = 0.01). Increased poly-ADP-ribose activity and mature muscle regeneration were associated with demand ischemia in the C57BL6 mice, compared with the ApoE-/- mice (P = 0.01).
CONCLUSIONS: Demand limb ischemia in the ApoE-/- phenotype exacerbated the expression of select systemic cytokines in plasma and blunted indices of muscle regeneration.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Exercise; Growth factors; Inflammation; Ischemia; Reperfusion; Skeletal muscle

Mesh:

Substances:

Year:  2013        PMID: 23528286      PMCID: PMC3713180          DOI: 10.1016/j.jss.2013.02.042

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  47 in total

1.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.

Authors:  Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

Review 2.  Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.

Authors:  E P Brass; W R Hiatt
Journal:  Vasc Med       Date:  2000       Impact factor: 3.239

3.  Apolipoprotein E suppresses the type I inflammatory response in vivo.

Authors:  Kamilah Ali; Melissa Middleton; Ellen Puré; Daniel J Rader
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

4.  Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo.

Authors:  C A Piot; J F Martini; S K Bui; C L Wolfe
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

5.  Effect of preconditioning with triiodothyronine on renal ischemia/reperfusion injury and poly(ADP-ribose) polymerase expression in rats.

Authors:  C Ferreyra; F O'Valle; J M Osorio; J M Moreno; I Rodríguez; F Vargas; A Osuna
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

6.  ROS and myokines promote muscle adaptation to exercise.

Authors:  Camilla Scheele; Søren Nielsen; Bente K Pedersen
Journal:  Trends Endocrinol Metab       Date:  2009-03-09       Impact factor: 12.015

7.  Enoxaparin does not ameliorate limb ischemia-reperfusion injury.

Authors:  Thomas A Abbruzzese; Hassan Albadawi; Jeanwan Kang; Virendra I Patel; Jin-Hyung Yoo; Glenn M Lamuraglia; Michael T Watkins
Journal:  J Surg Res       Date:  2008-04-08       Impact factor: 2.192

8.  Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.

Authors:  Eugenio Stabile; Mary Susan Burnett; Craig Watkins; Timothy Kinnaird; Alessia Bachis; Andrea la Sala; Jonathan M Miller; Matie Shou; Stephen E Epstein; Shmuel Fuchs
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

Review 9.  PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

Authors:  Andreína Peralta-Leal; José Manuel Rodríguez-Vargas; Rocío Aguilar-Quesada; María Isabel Rodríguez; José Luis Linares; Mariano Ruiz de Almodóvar; F Javier Oliver
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

Review 10.  Parthanatos, a messenger of death.

Authors:  Karen Kate David; Shaida Ahmad Andrabi; Ted Murray Dawson; Valina Lynn Dawson
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  5 in total

1.  Effect of limb demand ischemia on autophagy and morphology in mice.

Authors:  Hassan Albadawi; Rahmi Oklu; John D Milner; Thuy P Uong; Hyung-Jin Yoo; William G Austen; Michael T Watkins
Journal:  J Surg Res       Date:  2015-04-09       Impact factor: 2.192

Review 2.  Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.

Authors:  Peggy Sfyri; Antonios Matsakas
Journal:  J Biomed Sci       Date:  2017-07-08       Impact factor: 8.410

3.  Protective Effect of Edaravone Against Oxidative Stress in C2C12 Myoblast and Impairment of Skeletal Muscle Regeneration Exposed to Ischemic Injury in Ob/ob Mice.

Authors:  Takuya Nakanishi; Masaya Tsujii; Takahiro Asano; Takahiro Iino; Akihiro Sudo
Journal:  Front Physiol       Date:  2020-01-15       Impact factor: 4.566

Review 4.  Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia.

Authors:  Lucía Beltrán-Camacho; Marta Rojas-Torres; Mᵃ Carmen Durán-Ruiz
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

5.  Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation.

Authors:  Marta Tomczyk; Alicja Braczko; Patrycja Jablonska; Adriana Mika; Kamil Przyborowski; Agata Jedrzejewska; Oliwia Krol; Filip Kus; Tomasz Sledzinski; Stefan Chlopicki; Ewa M Slominska; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.